Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Predictive value of high-sensitivity troponin-I for future adverse cardiovascular outcome in stable patients with type 2 diabetes mellitus.

Yiu KH, Lau KK, Zhao CT, Chan YH, Chen Y, Zhen Z, Wong A, Lau CP, Tse HF.

Cardiovasc Diabetol. 2014 Mar 25;13:63. doi: 10.1186/1475-2840-13-63.

2.

High sensitivity troponin outperforms contemporary assays in predicting major adverse cardiac events up to two years in patients with chest pain.

Aldous SJ, Florkowski CM, Crozier IG, George P, Mackay R, Than M, Flaws DF, Borowsky J.

Ann Clin Biochem. 2011 May;48(Pt 3):249-55. doi: 10.1258/acb.2010.010220. Epub 2011 Mar 25. Erratum in: Ann Clin Biochem. 2012 Mar;49(Pt 2):208. Flaws, Dylan Finlay [added]; Borowsky, Jennifer [added].

PMID:
21441393
3.

Association of subclinical myocardial injury with arterial stiffness in patients with type 2 diabetes mellitus.

Yiu KH, Zhao CT, Chen Y, Siu CW, Chan YH, Lau KK, Liu S, Lau CP, Tse HF.

Cardiovasc Diabetol. 2013 Jun 22;12:94. doi: 10.1186/1475-2840-12-94.

4.

What does elevated high-sensitive troponin I in stroke patients mean: concomitant acute myocardial infarction or a marker for high-risk patients?

Anders B, Alonso A, Artemis D, Schäfer A, Ebert A, Kablau M, Fluechter S, Findeisen P, Hennerici MG, Fatar M.

Cerebrovasc Dis. 2013;36(3):211-7. doi: 10.1159/000353875. Epub 2013 Oct 12.

PMID:
24135532
5.

Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease.

Omland T, Pfeffer MA, Solomon SD, de Lemos JA, Røsjø H, Šaltytė Benth J, Maggioni A, Domanski MJ, Rouleau JL, Sabatine MS, Braunwald E; PEACE Investigators..

J Am Coll Cardiol. 2013 Mar 26;61(12):1240-9. doi: 10.1016/j.jacc.2012.12.026. Epub 2013 Feb 13. Erratum in: J Am Coll Cardiol. 2014 Jan 21;63(2):195-200.

6.

Prognostic value of troponin T and homocysteine in patients with end-stage renal disease.

Sahinarslan A, Güz G, Okyay K, Mutluay R, Yalçin R, Bali M, Sindel S, Cengel A.

Turk Kardiyol Dern Ars. 2008 Sep;36(6):382-7.

7.

Predicting myocardial infarction and other serious cardiac outcomes using high-sensitivity cardiac troponin T in a high-risk stable population.

McQueen MJ, Kavsak PA, Xu L, Shestakovska O, Yusuf S.

Clin Biochem. 2013 Jan;46(1-2):5-9. doi: 10.1016/j.clinbiochem.2012.10.003. Epub 2012 Oct 9.

PMID:
23063983
8.

Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome.

Cullen L, Mueller C, Parsonage WA, Wildi K, Greenslade JH, Twerenbold R, Aldous S, Meller B, Tate JR, Reichlin T, Hammett CJ, Zellweger C, Ungerer JP, Rubini Gimenez M, Troughton R, Murray K, Brown AF, Mueller M, George P, Mosimann T, Flaws DF, Reiter M, Lamanna A, Haaf P, Pemberton CJ, Richards AM, Chu K, Reid CM, Peacock WF, Jaffe AS, Florkowski C, Deely JM, Than M.

J Am Coll Cardiol. 2013 Oct 1;62(14):1242-9. doi: 10.1016/j.jacc.2013.02.078. Epub 2013 Apr 10.

9.

Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease).

White HD, Tonkin A, Simes J, Stewart R, Mann K, Thompson P, Colquhoun D, West M, Nestel P, Sullivan D, Keech AC, Hunt D, Blankenberg S; LIPID Study Investigators..

J Am Coll Cardiol. 2014 Feb 4;63(4):345-54. doi: 10.1016/j.jacc.2013.08.1643. Epub 2013 Oct 30.

10.

Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients.

Hickman PE, McGill DA, Talaulikar G, Hiremagalur B, Bromley J, Rahman A, Koerbin G, Southcott E, Potter JM.

Intern Med J. 2009 Dec;39(12):812-8. doi: 10.1111/j.1445-5994.2009.01846.x.

PMID:
20233242
11.

High-sensitivity troponin level pre-catheterization predicts adverse cardiovascular outcomes after primary angioplasty for ST-elevation myocardial infarction.

Wang TK, Snow TA, Chen Y, Rostom H, White JM, Stewart JT, Webster MW, Ruygrok PN, Watson T, White HD.

Eur Heart J Acute Cardiovasc Care. 2014 Jun;3(2):118-25. doi: 10.1177/2048872614527006. Epub 2014 Feb 27.

PMID:
24576774
12.

Cardiac troponins have no prognostic value for acute and chronic cardiac events in asymptomatic patients with end-stage renal failure.

Lang K, Schindler S, Forberger C, Stein G, Figulla HR.

Clin Nephrol. 2001 Jul;56(1):44-51.

PMID:
11499658
13.

Postoperative levels of cardiac troponin versus CK-MB and high-sensitivity C-reactive protein for the prediction of 1-year cardiovascular outcome in patients undergoing vascular surgery.

Kouvelos GN, Milionis HJ, Arnaoutoglou EM, Chasiotis G, Gartzonika C, Papa NK, Tzimas P, Matsagkas MI.

Coron Artery Dis. 2011;22(6):428-34. doi: 10.1097/MCA.0b013e3283487d96.

PMID:
21730823
14.

Troponin I levels in permanent atrial fibrillation-impact of rate control and exercise testing.

Horjen AW, Ulimoen SR, Enger S, Norseth J, Seljeflot I, Arnesen H, Tveit A.

BMC Cardiovasc Disord. 2016 May 4;16:79. doi: 10.1186/s12872-016-0255-x.

15.
16.

Troponin I as a prognostic marker of cardiac events in asymptomatic hemodialysis patients using a sensitive troponin I assay.

Gaiki MR, DeVita MV, Michelis MF, Panagopoulos G, Rosenstock JL.

Int Urol Nephrol. 2012 Dec;44(6):1841-5. doi: 10.1007/s11255-012-0128-x. Epub 2012 Feb 5.

PMID:
22311387
17.

Gender, High-Sensitivity Troponin I, and the Risk of Cardiovascular Events (from the Nord-Trøndelag Health Study).

Lyngbakken MN, Røsjø H, Holmen OL, Nygård S, Dalen H, Hveem K, Omland T.

Am J Cardiol. 2016 Sep 15;118(6):816-21. doi: 10.1016/j.amjcard.2016.06.043. Epub 2016 Jun 28.

PMID:
27453509
18.

Impact of diabetes on the predictive value of heart failure biomarkers.

Alonso N, Lupón J, Barallat J, de Antonio M, Domingo M, Zamora E, Moliner P, Galán A, Santesmases J, Pastor C, Mauricio D, Bayes-Genis A.

Cardiovasc Diabetol. 2016 Nov 3;15(1):151.

19.

Prognostic value of troponin I levels for predicting adverse cardiovascular outcomes in postmenopausal women undergoing cardiac surgery.

Stearns JD, Dávila-Román VG, Barzilai B, Thompson RE, Grogan KL, Thomas B, Hogue CW Jr.

Anesth Analg. 2009 Mar;108(3):719-26. doi: 10.1213/ane.0b013e318193fe73.

PMID:
19224775
20.

High-sensitivity C-reactive protein can predict major adverse cardiovascular events in Korean patients with type 2 diabetes.

Lee S, Kim IT, Park HB, Hyun YK, Kim YJ, Song SO, Kim H.

J Korean Med Sci. 2011 Oct;26(10):1322-7. doi: 10.3346/jkms.2011.26.10.1322. Epub 2011 Oct 1.

Supplemental Content

Support Center